Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 4, 2004 - Issue 2
Submit an article Journal homepage
20
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluation

Ziprasidone: a novel psychotropic with unique properties

Christos Ballas PEEC, Ground Floor, Ravdin Building, 3400 Spruce St., Philadelphia, PA 19104, USA. [email protected]
,
Calvin Yang PEEC, Ground Floor, Ravdin Building, 3400 Spruce St., Philadelphia, PA 19104, USA. [email protected]
,
John O’Reardon PEEC, Ground Floor, Ravdin Building, 3400 Spruce St., Philadelphia, PA 19104, USA. [email protected]
,
Paul Ballas PEEC, Ground Floor, Ravdin Building, 3400 Spruce St., Philadelphia, PA 19104, USA. [email protected]
&
Claudia Baldassano PEEC, Ground Floor, Ravdin Building, 3400 Spruce St., Philadelphia, PA 19104, USA. [email protected]
Pages 179-186 | Published online: 10 Jan 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Susan L McElroy, Anna Guerdjikova, Nicole Mori & Paul E Keck Jr. (2010) Therapeutic potential of new second generation antipsychotics for major depressive disorder. Expert Opinion on Investigational Drugs 19:12, pages 1527-1544.
Read now

Articles from other publishers (12)

Young-Hoon KoKyoung-Sae NaChul-Eung KimSeung-Hyun KimYang-Whan JeonJung-Seo YiMoon-Soo LeeShin-Gyeom KimHyun-Ghang JeongHan-Yong Jung. (2014) The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder. Psychiatry Investigation 11:4, pages 459.
Crossref
Jerry Altshuler & Brian Spoelhof. (2013) Pain, Agitation, Delirium, and Neuromuscular Blockade. Critical Care Nursing Quarterly 36:4, pages 356-369.
Crossref
W. Wolfgang Fleischhacker & Alex Hofer. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie 937 960 .
Alette M. Wessels, Robert R. Bies, Bruce G. Pollock, Lon S. Schneider, Jeffrey A. Lieberman, Scott Stroup, Claire H. Li, Kim Coley, Margaret M. Kirshner & Stephen R. Marder. (2011) Population Pharmacokinetic Modeling of Ziprasidone in Patients With Schizophrenia From the CATIE Study. The Journal of Clinical Pharmacology 51:11, pages 1587-1591.
Crossref
Chiara MatteiMaria Paola RapagnaniStephen M. Stahl. (2011) Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?. Journal of Central Nervous System Disease 3, pages JCNSD.S4138.
Crossref
Charles DeBattista & Jessica Hawkins. (2009) Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression. CNS Drugs 23:5, pages 369-377.
Crossref
Maria D Chermá, Margareta Reis, Staffan Hägg, Johan Ahlner & Finn Bengtsson. (2008) Therapeutic Drug Monitoring of Ziprasidone in a Clinical Treatment Setting. Therapeutic Drug Monitoring 30:6, pages 682-688.
Crossref
Alessandro Rossi, Antonio Vita, Paola Tiradritti & Fabio Romeo. (2008) Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone. International Clinical Psychopharmacology 23:4, pages 216-222.
Crossref
W. Wolfgang Fleischhacker, Martina Hummer & Alex Hofer. 2008. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie 847 872 .
Lewis Warrington, Ilise Lombardo, Antony Loebel & Kathleen Ice. (2007) Ziprasidone for the Treatment of Acute Manic or Mixed Episodes Associated with Bipolar Disorder. CNS Drugs 21:10, pages 835-849.
Crossref
I. R. De Oliveira & M. F. Juruena. (2006) Treatment of psychosis: 30 years of progress. Journal of Clinical Pharmacy and Therapeutics 31:6, pages 523-534.
Crossref
W. W. Fleischhacker & M. Hummer. (2006) Pharmakotherapie der SchizophreniePharmacotherapy for schizophrenia. Der Nervenarzt 77:S03, pages S77-S98.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.